+Compare
PROF
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
232.26M

PROF Profound Medical Corp Forecast, Technical & Fundamental Analysis

a developer and manufacturee of therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for PROF with price predictions
07:00 PM EST Nov 30, 2023

PROF saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for PROF moved out of overbought territory on November 22, 2023. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 55 similar instances where the indicator exited the overbought zone. In of the 55 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for PROF moved out of overbought territory on November 21, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PROF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PROF broke above its upper Bollinger Band on November 17, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 03, 2023. You may want to consider a long position or call options on PROF as a result. In of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PROF just turned positive on November 03, 2023. Looking at past instances where PROF's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

PROF moved above its 50-day moving average on November 15, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PROF crossed bullishly above the 50-day moving average on November 15, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PROF advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 199 cases where PROF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PROF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.656) is normal, around the industry mean (25.181). P/E Ratio (0.000) is within average values for comparable stocks, (79.550). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.249). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (33.333) is also within normal values, averaging (44.232).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PROF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.4B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 4%. For the same Industry, the average monthly price growth was 13%, and the average quarterly price growth was 704%. LNDZF experienced the highest price growth at 347%, while SDCCQ experienced the biggest fall at -31%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 107%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was 13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 60
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: 17 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

PROF is expected to report earnings to rise 17.96% to -30 cents per share on March 05

Profound Medical Corp PROF Stock Earnings Reports
Q4'23
Est.
$-0.31
Q3'23
Beat
by $0.08
Q2'23
Beat
by $0.70
Q1'23
Beat
by $0.69
Q4'22
Missed
by $0.09
The last earnings report on November 02 showed earnings per share of -25 cents, beating the estimate of -34 cents. With 9.69K shares outstanding, the current market capitalization sits at 232.26M.
A.I. Advisor
published General Information

General Information

a developer and manufacturee of therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
2400 Skymark Avenue
Phone
+1 647 476-1350
Employees
131
Web
https://www.profoundmedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ASVIX9.590.31
+3.34%
American Century Small Cap Value Inv
TRMSX16.730.37
+2.26%
T. Rowe Price Mid-Cap Index I
APDWX9.300.12
+1.31%
Artisan Value Income Advisor
WFATX38.970.29
+0.75%
Allspring Index Asset Allocation Instl
NEMCX16.74-0.02
-0.12%
Neuberger Berman Emerg Mkts Eq C

PROF and

Correlation & Price change

A.I.dvisor tells us that PROF and GH have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PROF and GH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROF
1D Price
Change %
PROF100%
+0.62%
GH - PROF
25%
Poorly correlated
+4.61%
SENS - PROF
24%
Poorly correlated
+8.34%
BIO - PROF
24%
Poorly correlated
+0.68%
SEQL - PROF
24%
Poorly correlated
N/A
HSDT - PROF
23%
Poorly correlated
+2.52%
More

Groups containing PROF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROF
1D Price
Change %
PROF100%
+0.62%
north america
(undefined stocks)
19%
Poorly correlated
+2.17%
Medical Specialties
(undefined stocks)
17%
Poorly correlated
+1.41%
Medical Specialties
(undefined stocks)
17%
Poorly correlated
+1.41%